Silencing E-cadherin impaired the bacterium's ability to induce inflammation and drive cell cycle progression, suggesting that F. nucleatum exploits E-cadherin to facilitate CRC development and may represent a promising target for antimicrobial therapeutic strategies [20]. Here, CDH1 is linked to colorectal carcinoma.